glp-1 news today pharma health obesity drugs october 2025 Outlook for obesity in 2025: more GLP-1 Safety Check - National
Description
Use of these drugs is much higher among adults who are currently covered by health insurance compared to those who are uninsured (12% v
both approaches are acceptable
Always follow your providers instructions when pausing or restarting any prescription
There is mounting evidence to suggest GLP-1 obesity treatments also help reduce cancer risk, according to several recent studies
